We are live on ! Find out more
BEAT

BioTelemetry, Inc.
BEAT

Delisted

BEAT was delisted on the 8th of February, 2021.

85 hedge funds and large institutions have $132M invested in BioTelemetry, Inc. in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 33 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

3% less repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 33

7% less capital invested

Capital invested by funds: $142M → $132M (-$9.84M)

9% less funds holding

Funds holding: 9385 (-8)

42% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 19

69% less call options, than puts

Call options by funds: $191K | Put options by funds: $612K

Holders
85
Holders Change
-8
Holders Change %
-8.6%
% of All Funds
2.47%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
11
Increased
32
Reduced
33
Closed
19
Calls
$191K
Puts
$612K
Net Calls
-$421K
Net Calls Change
+$417K
Name Holding Trade Value Shares
Change
Change in
Stake
Barclays
76
Barclays
United Kingdom
$15K +$2.03K +290 +14%
BNP Paribas Financial Markets
77
BNP Paribas Financial Markets
France
$10.7K +$8.63K +1,230 +344%
TDC
78
Thompson Davis & Co
Virginia
$10K -$3.51K -500 -25%
GSC
79
Ground Swell Capital
South Carolina
$10K +$10.6K +1,509 New
TRCT
80
Tower Research Capital (TRC)
New York
$8K -$87.8K -12,515 -91%
Deutsche Bank
81
Deutsche Bank
Germany
$8K +$750 +107 +9%
Creative Planning
82
Creative Planning
Kansas
$7K
Citigroup
83
Citigroup
New York
$6K +$4.87K +694 +311%
GT
84
Glenmede Trust
Pennsylvania
$5K -$4.27K -609 -43%
Manulife (Manufacturers Life Insurance)
85
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$114 -$3.43K -489 -3%
Fuller & Thaler Asset Management
86
Fuller & Thaler Asset Management
California
-$2.6M -362,850 Closed
WMSA
87
Weiss Multi-Strategy Advisers
New York
-$359K -50,000 Closed
JP Morgan Chase
88
JP Morgan Chase
New York
-$357K -49,796 Closed
Capital Fund Management (CFM)
89
Capital Fund Management (CFM)
France
-$308K -43,000 Closed
Jane Street
90
Jane Street
New York
-$277K -38,569 Closed
EGA
91
Eagle Global Advisors
Texas
-$266K -37,050 Closed
SG Americas Securities
92
SG Americas Securities
New York
-$249K -34,774 Closed
ZIM
93
Zacks Investment Management
Illinois
-$249K -34,719 Closed
Marshall Wace
94
Marshall Wace
United Kingdom
-$204K -28,453 Closed
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
-$158K -22,066 Closed
Goldman Sachs
96
Goldman Sachs
New York
-$142K -19,819 Closed
GC
97
Guggenheim Capital
Illinois
-$101K -14,057 Closed
FA
98
FDx Advisors
Illinois
-$84K -11,692 Closed
CSS
99
Cubist Systematic Strategies
Connecticut
-$74K -10,367 Closed
VFA
100
Virtus Fund Advisers
Connecticut
-$16K -2,252 Closed

BEAT Hedge Fund Activity: Q3 2014 in Review

85 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in BioTelemetry, Inc. (BEAT) for Q3 2014, worth a combined $132M — down 6.9% from $142M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of BEAT and 11 opened new positions — a net loss of 8 holders — while 33 trimmed existing stakes and 32 added.

The largest buyer was Deerfield Management, opening a new position worth an estimated $5.81M. The largest seller was Columbia Partners Investment Management, cutting an estimated $7.66M.

  • 85 institutional investors held BioTelemetry, Inc. (BEAT) as of Q3 2014, down from 93 in Q2 2014.
  • Funds reported $132M of BioTelemetry, Inc. stock for Q3 2014, down 6.9% quarter-over-quarter.
  • 11 funds opened new BioTelemetry, Inc. positions in Q3 2014 and 19 closed out, a net change of -8 holders.
  • The largest BioTelemetry, Inc. buyer in Q3 2014 was Deerfield Management, an estimated $5.81M added.
  • The largest BioTelemetry, Inc. seller in Q3 2014 was Columbia Partners Investment Management, an estimated $7.66M sold.

Based on aggregated 13F filings for Q3 2014.